QCPP in Practice

Get the latest reminders and updates delivered to your inbox, or read the updates online below.

  • Maintaining integrity and enhancing transparency

    Aug 09, 2017

    Did you know:

    • ·All pharmacies pay the same QCPP annual fee?
    • ·QCPP does not develop AS85000?

    The most significant touch point pharmacies have with QCPP is normally in the lead up to and during your QCPP assessment. But, were you aware of the checks and balances in the background which ensure you get a fair assessment? In this QIP, we describes some of the ways which we ensure integrity and fairness in our program.

    Accrediting to the Australian Standard

    QCPP accredits pharmacies to AS85000:2011 Quality Care Pharmacy Standard: A quality management system for pharmacies in Australia (AS85000:2011). This Standard is developed and revised through a Standards Australia compliant process, which is developed by a committee of relevant industry stakeholders - including consumers, pharmacies and pharmacy organisations. While AS85000 was initially developed from earlier versions of the QCPP Requirements, QCPP is not a party to the ongoing development of AS85000.

    The QCPP Requirements reflect the application of AS85000:2011. All requirements of the program are linked to determining compliance with AS85000:2011.

    External oversight

    JASANZ (Joint Accreditation Scheme for Australia and New Zealand) are our accrediting body, who oversee QCPP operations. This includes checks of independence in process, systems and decision making.

    Commitment to fairness

    Governance structures to ingrain fairness

    QCPP's impartiality committee oversees the independence of program operations. This includes a mandate to ensure program rules, requirements, policies and audit criteria do not unfairly disadvantage any pharmacy or group of pharmacies. The committee also oversees complaints handling and appeals.

    Conflict of interest management

    QCPP and EY have robust conflict of interest policies in place to ensure fair assessment outcomes free of undue influence. Pharmacies who identify a potential conflict of interest with an assessor, QCPP personnel or other relevant person, please contact help@qcpp.com or 1300 363 340 for a confidential discussion on how the conflict can be managed.

    Flat fee structure

    All pharmacies pay the same accreditation fees, which included a fee reduction introduced in July 2017. This fee continues to cover the travel costs incurred in undertaking QCPP assessments in pharmacies across all of Australia.

    Further enhancing transparency of QCPP operations

    QCPP is committed to clarity and transparency in the operation of our program. A number of decisions or outcomes are subject to appeal, such as assessment and accreditation outcomes. Some forms of appeal, such as extension requests and remedial review requests can be accessed via our website at https://www.qcpp.com/resources/tools/qcpp-forms. All other appeals can be initiated by emailing help@qcpp.com

    Transparency will be further enhanced through the release of the QCPP Handbook later this year, which describes more clearly how QCPP makes decisions, such as accreditation, requests for extensions, review of remedial actions and exceptional circumstances etc.

    Find out more!


    Education events

    QCPP was excited to connect with pharmacies at the WA Pharmacy Forum in Perth last week about the improvements to QCPP. Pharmacists we spoke to reflected positively on recent assessment experiences and were keen to learn more about the revised QCPP Requirements.

    Pharmacy Connect, Sydney: Saturday 2 - Sunday 3 September.

    Simon Carroll will be presenting on Sunday 13.30pm on the revised QCPP Requirements and how they have been designed to help your pharmacy innovate and grow. The session will also discuss how QCPP Assessment against the requirements will be more flexible through recognising professional standards and guidelines. The QCPP team will also have a stand to engage with conference delegates.



  • Transition: What happens now?

    Jul 12, 2017

    Following the release of the revised QCPP Requirements in June, QCPP is focusing on rolling out an improved assessment experience for pharmacies against these requirements.

    QCPP and our assessment partners, Ernst and Young (EY) are currently developing a new assessment tool that aligns with the updated requirements. This will be trialed during October 2017 through a pilot assessment program.

    The pilot program will include 20 assessments against the updated requirements using the newly developed assessment tool and methodology. Pharmacies involved in the pilot will play a vital role in providing feedback on the assessment experience. QCPP and EY will use this feedback to optimise the assessment tool and methodology to create an assessment which supports and enhances excellence in your pharmacy.

    EY will begin contacting those pharmacies that have been identified as suitable candidates for the pilot program in the coming weeks. If you are invited to participate we encourage you to take the opportunity to be a key part in creating an assessment process that recognises the innovation and development occurring in modern community pharmacy. All other pharmacies will continue to be assessed under the current requirements until the end of 2017, with full transition to the updated requirements occurring early in 2018.

    The updated requirements and a series of webinars supporting QCPP enhancements can be found in the Knowledge Hub. We encourage pharmacies to start familiarising themselves with this information now.

     

     

    For pharmacy owners and staff attending upcoming pharmacy industry events, QCPP is pleased to announce education sessions and trade stands where you can ask questions about the exciting changes to QCPP or just come have a chat about your pharmacy accreditation.

    Come and speak with our team at the following upcoming events:

    • Pharmacy WA The Forum, Perth: 3rd – 4th August, 2017 – trade stand
    • Pharmacy Connect, Sydney: 1st – 3rd September, 2017 – trade stand and education session
    • Pharmacy Assistant Conference, Gold Coast: 26th – 28th October – trade stand and education session


  • Make the most of your remedial action evidence

    Jun 15, 2017
     

     

    Our assessment partner EY operate a centralised office which considers all remedial actions.The centralised office allows for consistent and efficient consideration of remedial action evidence.

    To help pharmacies close remedial actions smoothly, QCPP have prepared some tips to submitting remedial action evidence:
    1. Describe how submitted evidence relates to the remedial action

    The team reviewing remedial actions are external to your pharmacy. While the team works hard to consider how the evidence relates to each remedial action, this is not always obvious. Describing how the evidence relates to the remedial action is important to ensure the context of the evidence is understood and reduces emails seeking further clarification.

    1. Faxes: include a cover sheet

    When supplying evidence via fax, a cover sheet is important to accurately identify the pharmacy and understand the evidence submitted. We recommend the cover sheet include pharmacy contact details and the remedial actions the evidence relates to.

    1. Allow adequate time

    While pharmacies have 3 months from the date of assessment to close remedial actions, we recommend submitting evidence as soon as possible. This allows adequate time for the pharmacy to make further corrections should the evidence submitted not close the remedial action.

    How do I know my evidence has been received?
    Emails to qcppremedials@au.ey.com are acknowledge instantly via email. If you do not receive this confirmation, it is likely EY have not received your email.
    Faxes are not able to be automatically acknowledged. If you have not received a response within 1-2 business days, we recommend contacting qcppremedials@au.ey.com in the first instance to determine whether your evidence has been received.

    What happens to remedial action evidence faxed to EY?
    When EY is faxed on (03) 8650 7920, they receive an email message with the faxed document in PDF format. Once the PDF is reviewed, EY will send an email to the address listed on a pharmacy’s interim report (unless they have been notified to change email addresses). This message will communicate whether all remedial actions have been resolved or will describe outstanding items.

    How long does it take to review my remedial action evidence?
    EY’s PMO will respond to remedial action evidence submitted within 1-2 business days. If you have not received a response in this time, please contact qcppremedials@au.ey.com.

    My remedial report asks for a signed statement. What is this?
    A signed statement is a commitment from the pharmacy an action will be taken in the future. Where this is submitted by fax, this must be signed by the owner or authorised delegate. Where submitted via email, a statement from a recognised email address will be considered as a signed statement.

    If you have queries about your remedial actions, contact qcppremedials@au.ey.com. For all other questions about your accreditation, contact QCPP via:

     

     

    Webinar content now available on QCPP Knowledge Hub!

    We are pleased to announce content from our recent successful webinar series is now available on the QCPP Knowledge Hub. Pharmacy feedback

    Individual ‘bite sized’ segments of the webinar available include:

    • Improved QCPP: Overview of key enhancements
    • Revised QCPP Requirements
    • Revised QCPP Rules
    • QCPP Fees
    • Transition arrangements
    • Questions and answers

    The webinar content can be accessed by

    1. logging into www.qcpp.com/knowledgehub
    2. Clicking on ‘QCPP improvements from July 2017’.


Advertisement


© The Pharmacy Guild of Australia | Disclaimer | Privacy Policy | Contact Us

view Mode